MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Cash Flow

Whitehawk Therapeutics, Inc. (WHWK)

Whitehawk Therapeutics, Inc. (WHWK)

source: myfinsight.com
DownloadDownload image
Maturity of short-terminvestments$38,616K Net cash provided byinvesting activities$19,430K Canceled cashflow$19,186K Net (decrease)increase in cash and cash...-$2,778K Canceled cashflow$19,430K Share-based compensationexpense$2,193K Prepaid expenses andother current assets-$1,470K Other non-currentassets-$163K Purchase of short-terminvestments$19,186K Net cash used inoperating activities-$22,208K Canceled cashflow$3,826K Net (loss) income-$22,194K Accounts payable andaccrued liabilities-$3,494K Discount amortization onshort-term investments$347K